XML 47 R24.htm IDEA: XBRL DOCUMENT v3.21.1
Stockholders' Equity (Details) - shares
 3 Months Ended
Mar. 09, 2021
Mar. 31, 2021
May 17, 2021
Mar. 16, 2021
Feb. 12, 2021
Dec. 30, 2020
Stockholders' Equity (Details) [Line Items]            
Shares issued         63,626,903  
Sale of subsidiaries, description   In particular, CVR holders will be entitled to any consideration (whether cash, stock, assets or otherwise) that Mawson or the Mawson Subsidiaries (or any of its Affiliates or shareholders) receives in connection with an LO2A Transaction, which, as defined in the CVR Agreement, and which includes (i) a sale of any of the Mawson Subsidiaries to a third party and/or (ii) the partnering, licensing, sublicensing, distribution, reselling or sale of all or any part of the LO2A Technology or LO2A Products to a third party, less transaction expenses and customary deductions as detailed in the CVR agreement, including a deduction of up to $300,000 that the Mawson Subsidiaries undertook to incur in the development of the LO2A Technology at the request of the Holders’ Representative.        
Percentage of outstanding shares       10.00%    
Cosmos Transaction [Member]            
Stockholders' Equity (Details) [Line Items]            
Shares issued 428,270,616         25,000,000
Common Stock available for future grant           409,999
Remaining shares 50,558,133 50,558,133        
Total quantity of shares issued 478,828,749          
Restricted shares   18,474,278        
Cosmos Transaction [Member] | Subsequent Event [Member]            
Stockholders' Equity (Details) [Line Items]            
Shares issued     428,270,616      
Restricted shares     156,492,928      
Warrant [Member]            
Stockholders' Equity (Details) [Line Items]            
Issued shares of common stock 115,902          
Series A Preferred Stock [Member] | Subsequent Event [Member]            
Stockholders' Equity (Details) [Line Items]            
Shares issued     178,000